NDC 15370-170 – Relafen Ds
Nabumetone 1000 mg/1 · Tablet · Oral
Product NDC15370-170
Product details
- Brand name
- Relafen Ds
- Generic name
- Nabumetone
- Labeler
- Carwin Pharmaceutical Associates, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA203166
- Marketed since
- September 20, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Active ingredients
- Nabumetone 1000 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 15370-170-10 | 100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10) | May 12, 2022 |
| 15370-170-30 | 30 TABLET in 1 BOTTLE, PLASTIC (15370-170-30) | Sep 20, 2019 |
| 15370-170-60 | 60 TABLET in 1 BOTTLE, PLASTIC (15370-170-60) | Feb 28, 2020 |
| 15370-170-99 sample | 1 BLISTER PACK in 1 CARTON (15370-170-99) / 2 TABLET in 1 BLISTER PACK | Feb 28, 2020 |